Sertraline for anxiety in adults with a diagnosis of autism (STRATA): study protocol for a pragmatic, multicentre, double-blind, placebo-controlled randomised controlled trial
This publication is included in the Autistic Autism Scholarship Project. three authors of this publication are identified as autistic in the project.
About the autistic author markerRai, D., Webb, D., Lewis, A., Cotton, L., Norris, J. E., Alexander, R., Baldwin, D. S., Brugha, T., Cochrane, M., Del Piccolo, M. C., Glasson, E. J., Hatch, K. K., Kessler, D., Langdon, P. E., Leonard, H., MacNeill, S. J., Mills, N., Morales, M. V., Morgan, Z.,..., & Wiles, N. (2024). Sertraline for anxiety in adults with a diagnosis of autism (STRATA): study protocol for a pragmatic, multicentre, double-blind, placebo-controlled randomised controlled trial. Trials, 25(1), 37-37. https://doi.org/10.1186/s13063-023-07847-3
This publication is integrated into AutiHub through:
Authors
Abstract
Abstract Background Selective serotonin reuptake inhibitors (SSRIs) are commonly prescribed to manage anxiety in adults with an autism diagnosis. However, their effectiveness and adverse effect profile in the autistic population are not well known. This trial aims to determine the effectiveness and cost-effectiveness of the SSRI sertraline in reducing symptoms of anxiety and improving quality of life in adults with a diagnosis of autism compared with placebo and to quantify any adverse effects. Methods STRATA is a two-parallel group, multi-centre, pragmatic, double-blind, randomised placebo-controlled trial with allocation at the level of the individual. It will be delivered through recruiting sites with autism services in 4 regional centres in the United Kingdom (UK) and 1 in Australia. Adults with an autism diagnosis and a Generalised Anxiety Disorder Assessment (GAD-7) score ≥ 10 at screening will be randomised 1:1 to either 25 mg sertraline or placebo, with subsequent flexible dose titration up to 200 mg. The primary outcome is GAD-7 scores at 16 weeks post-randomisation. Secondary outcomes include adverse effects, proportionate change in GAD-7 scores including 50% reduction, social anxiety, obsessive-compulsive symptoms, panic attacks, repetitive behaviours, meltdowns, depressive symptoms, composite depression and anxiety, functioning and disability and quality of life. Carer burden will be assessed in a linked carer sub-study. Outcome data will be collected using online/paper methods via video call, face-to-face or telephone according to participant preference at 16, 24 and 52 weeks post-randomisation, with brief safety checks and data collection at 1–2, 4, 8, 12 and 36 weeks. An economic evaluation to study the cost-effectiveness of sertraline vs placebo and a QuinteT Recruitment Intervention (QRI) to optimise recruitment and informed consent are embedded within the trial. Qualitative interviews at various times during the study will explore experiences of participating and taking the trial medication. Discussion Results from this study should help autistic adults and their clinicians make evidence-based decisions on the use of sertraline for managing anxiety in this population. Trial registration ISRCTN, ISRCTN15984604. Registered on 08 February 2021. EudraCT 2019-004312-66. ANZCTR ACTRN12621000801819. Registered on 07 April 2021.
Bibliography cited by this reference
Cited references are imported from external metadata sources when they are available. The list may be partial.
Cited bibliography overview
These indicators describe the bibliography cited by this publication. An author name is counted each time it appears in one cited reference, so the same person can be counted more than once. Names not yet linked to an author already present in AutiHub are treated as unknown, not as non-autistic. Last computed: 12 Sep 2026 18:20.
- With a DOI
- 46
- Without a DOI, from raw bibliography text
- 11
- References with detected author names
- 49 / 57 (86.0%)
- Without detected author names
- 8
- Without a structured title
- 10
- Without a stable identifier
- 11
- References with raw author names still to review
- 8
- References with external metadata lookup issues
- 0
- From DOI or external metadata
- 345
- From validated raw bibliography text
- 0
- Raw names already validated
- 0
- Raw names still to review
- 10
-
Karen A. Robinson , Victor D. Dinglas , Vineeth Sukrithan , Ramakrishna Yalamanchilli , Pedro A. Mendez-Tellez , Cheryl Dennison-Himmelfarb et al. (2015). Updated systematic review identifies substantial number of retention strategies: using more strategies retains more study participants . Journal of Clinical Epidemiology, 68(12), 1481-1487. Elsevier BV.Crossref OpenAlex OpenCitations
-
Meng-Chuan Lai , Michael Lombardo , Simon Baron-Cohen (2014). Autism . The Lancet, 383(9920), 896-910. Elsevier BV.Crossref OpenAlex OpenCitations
-
K. Jobski , J. Höfer , F. Hoffmann , C. Bachmann (2017). Use of psychotropic drugs in patients with autism spectrum disorders: a systematic review . Acta Psychiatrica Scandinavica, 135(1), 8-28. Wiley.Crossref OpenAlex OpenCitations
-
Philip James Edwards , Ian Roberts , Mike J Clarke , Carolyn DiGuiseppi , Reinhard Wentz , Irene Kwan et al. (2009). Methods to increase response to postal and electronic questionnaires . Cochrane Database of Systematic Reviews, 2010(1), MR000008-MR000008. Wiley.OpenAlex
-
Matthew Hollocks , Jian Wei Lerh , Iliana Magiati , Richard Meiser-Stedman , Traolach Brugha (2019). Anxiety and depression in adults with autism spectrum disorder: a systematic review and meta-analysis . Psychological Medicine, 49(4), 559-572. Cambridge University Press (CUP).Crossref OpenAlex OpenCitations
-
Ilias Goranitis , Joanna Coast , Hareth Al-Janabi (2014). An investigation into the construct validity of the Carer Experience Scale (CES) . Quality of Life Research, 23(6), 1743-1752. Springer Science and Business Media LLC.Crossref OpenAlex OpenCitations
-
Tim Cadman , Debbie Spain , Patrick Johnston , Ailsa Russell , David Mataix-Cols , Michael Craig et al. (2015). Obsessive‐Compulsive Disorder in Adults with High‐Functioning Autism Spectrum Disorder: What Does Self‐Report with the OCI‐R Tell Us? Autism Research, 8(5), 477-485. Wiley.Crossref OpenAlex OpenCitations
-
Victoria Nimmo-Smith , Hein Heuvelman , Christina Dalman , Michael Lundberg , Selma Idring , Peter Carpenter et al. (2020). Anxiety Disorders in Adults with Autism Spectrum Disorder: A Population-Based Study . Journal of Autism and Developmental Disorders, 50(1), 308-318. Springer Science and Business Media LLC.Crossref OpenAlex OpenCitations
-
Shoumitro Deb , Meera Roy , Rachel Lee , Madiha Majid , Bharati Limbu , Jacopo Santambrogio et al. (2021). Randomised controlled trials of antidepressant and anti-anxiety medications for people with autism spectrum disorder: systematic review and meta-analysis . BJPsych Open, 7(6), e179. Royal College of Psychiatrists.Crossref OpenAlex OpenCitations
-
Sarah L. Barrett , Mirko Uljarević , Emma K Baker , Amanda Richdale , Catherine R. G. Jones , Susan Leekam (2015). The Adult Repetitive Behaviours Questionnaire-2 (RBQ-2A): A Self-Report Measure of Restricted and Repetitive Behaviours . Journal of Autism and Developmental Disorders, 45(11), 3680-3692. Springer Science and Business Media LLC.Crossref OpenAlex OpenCitations
-
Dheeraj Rai , Hein Heuvelman , Christina Dalman , Iryna Culpin , Michael Lundberg , Peter Carpenter et al. (2018). Association Between Autism Spectrum Disorders With or Without Intellectual Disability and Depression in Young Adulthood . JAMA Network Open, 1(4), e181465. American Medical Association (AMA).Crossref OpenAlex OpenCitations
-
James C. Ballenger (2004). Remission Rates in Patients With Anxiety Disorders Treated With Paroxetine . The Journal of Clinical Psychiatry, 65(12), 1696-1707. Physicians Postgraduate Press, Inc.Crossref OpenAlex OpenCitations
-
Kurt Kroenke , Robert L. Spitzer , Janet B.W. Williams , Patrick O. Monahan , Bernd Löwe (2007). Anxiety Disorders in Primary Care: Prevalence, Impairment, Comorbidity, and Detection . Annals of Internal Medicine, 146(5), 317-325. American College of Physicians.Type: Article DOI: 10.7326/0003-4819-146-5-200703060-00004 OpenAlex: https://openalex.org/W1995422036Crossref OpenAlex OpenCitations
-
Meng-Chuan Lai , Caroline Kassee , Richard Besney , Sarah Bonato , Laura Hull , Will Mandy et al. (2019). Prevalence of co-occurring mental health diagnoses in the autism population: a systematic review and meta-analysis . The Lancet Psychiatry, 6(10), 819-829. Elsevier BV.Crossref OpenAlex OpenCitations
-
Monte S. Buchsbaum , Eric Hollander , M. Mehmet Haznedar , Cheuk Tang , Jacqueline Spiegel-Cohen , Tse-Chung Wei et al. (2001). Effect of fluoxetine on regional cerebral metabolism in autistic spectrum disorders: a pilot study . The International Journal of Neuropsychopharmacology, 4(02), 119. Oxford University Press (OUP).Crossref OpenAlex OpenCitations
-
JFG Underwood (2022). Underwood JFG, DelPozo-Banos M, Frizzati A, Rai D, John A, Hall J. Neurological and psychiatric disorders among autistic adults: a population healthcare record study. Psychol Med. 2022;53(12):1–11. Psychol Med, 53(12), 1.Type: OtherCrossref
-
Eric Hollander , Latha Soorya , William Chaplin , Evdokia Anagnostou , Bonnie P. Taylor , Casara J. Ferretti et al. (2012). A Double-Blind Placebo-Controlled Trial of Fluoxetine for Repetitive Behaviors and Global Severity in Adult Autism Spectrum Disorders . American Journal of Psychiatry, 169(3), 292-299. American Psychiatric Association Publishing.Crossref OpenAlex OpenCitations
-
Tatja Hirvikoski , Ellenor Mittendorfer-Rutz , Marcus Boman , Henrik Larsson , Paul Lichtenstein , Sven Bölte (2016). Premature mortality in autism spectrum disorder . British Journal of Psychiatry, 208(3), 232-238. Royal College of Psychiatrists.Crossref OpenAlex OpenCitations
-
C.L. Muller , A.M.J. Anacker , Jeremy Veenstra‐VanderWeele (2016). The serotonin system in autism spectrum disorder: From biomarker to animal models . Neuroscience, 321, 24-41. Elsevier BV.Crossref OpenAlex OpenCitations
-
Glyn Lewis , Jean Mulligan , Nicola Wiles , Philip Cowen , Nick Craddock , Masashi Ikeda et al. (2011). Polymorphism of the 5-HT transporter and response to antidepressants: randomised controlled trial . British Journal of Psychiatry, 198(6), 464-471. Royal College of Psychiatrists.Crossref OpenAlex OpenCitations
-
Audrey Linden , Lawrence MJ Best , Freya Elise *Autistic author. Learn more… , Danielle Roberts , Aoife Branagan , Yong Boon Ernest Tay et al. (2023). Benefits and harms of interventions to improve anxiety, depression, and other mental health outcomes for autistic people: A systematic review and network meta-analysis of randomised controlled trials . Autism, 27(1), 7-30. SAGE Publications.
-
The EuroQol Group (1990). EuroQol - a new facility for the measurement of health-related quality of life . Health Policy, 16(3), 199-208. Elsevier BV.Crossref OpenAlex OpenCitations
-
Peter D. Londborg , Robert Wolkow , Ward T. Smith , Eugene Duboff , Donald England , James Ferguson et al. (1998). Sertraline in the treatment of panic disorder . British Journal of Psychiatry, 173(1), 54-60. Royal College of Psychiatrists.Crossref OpenAlex OpenCitations
-
Connor M. Kerns , Philip C. Kendall , Leandra Berry , Margaret C. Souders , Martin E. Franklin , Robert T. Schultz et al. (2014). Traditional and Atypical Presentations of Anxiety in Youth with Autism Spectrum Disorder . Journal of Autism and Developmental Disorders, 44(11), 2851-2861. Springer Science and Business Media LLC.Crossref OpenAlex OpenCitations
-
Robert L. Spitzer , Kurt Kroenke , Janet B. W. Williams , Bernd Löwe (2006). A Brief Measure for Assessing Generalized Anxiety Disorder . Archives of Internal Medicine, 166(10), 1092. American Medical Association (AMA).Crossref OpenAlex OpenCitations
-
Valentina Postorino , Connor M. Kerns , Giacomo Vivanti , Jessica Bradshaw , Martina Siracusano , Luigi Mazzone (2017). Anxiety Disorders and Obsessive-Compulsive Disorder in Individuals with Autism Spectrum Disorder . Current Psychiatry Reports, 19(12), 92. Springer Science and Business Media LLC.Crossref OpenAlex OpenCitations
-
Kenneth F. Schulz , Doug Altman , David Moher , for the CONSORT Group* (2010). CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomized Trials . Annals of Internal Medicine, 152(11), 726-732. American College of Physicians.Type: Article DOI: 10.7326/0003-4819-152-11-201006010-00232 OpenAlex: https://openalex.org/W2049103906Crossref OpenAlex OpenCitations
-
David S. Baldwin , Ian M Anderson , David J Nutt , Christer Allgulander , Borwin Bandelow , Johan A den Boer et al. (2014). Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology . Journal of Psychopharmacology, 28(5), 403-439. SAGE Publications.Crossref OpenAlex OpenCitations
-
Paul A. Harris , Robert Taylor , Robert Thielke , Jonathon Payne , Nathaniel Gonzalez , Jose G. Conde (2009). Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support . Journal of Biomedical Informatics, 42(2), 377-381. Elsevier BV.Crossref OpenAlex OpenCitations
-
D Taylor (2015). South London and Maudsley NHS Trust: The Maudsley prescribing guidelines in psychiatry . South London and Maudsley NHS Trust: The Maudsley prescribing guidelines in psychiatry.Type: OtherCrossref
-
Gemma Lewis , Larisa Duffy , Anthony Ades , Rebekah Amos , Ricardo Araya , Sally Brabyn et al. (2019). The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomised trial . The Lancet Psychiatry, 6(11), 903-914. Elsevier BV.Crossref OpenAlex OpenCitations
-
Kurt Kroenke , Jingwei Wu , Zhangsheng Yu , Matthew J. Bair , Jacob Kean , Timothy Stump et al. (2016). Patient Health Questionnaire Anxiety and Depression Scale: Initial Validation in Three Clinical Trials . Psychosomatic Medicine, 78(6), 716-727. Ovid Technologies (Wolters Kluwer Health).Crossref OpenAlex OpenCitations
-
Christopher J. McDougle (1996). A Double-blind, Placebo-Controlled Study of Fluvoxamine in Adults With Autistic Disorder . Archives of General Psychiatry, 53(11), 1001. American Medical Association (AMA).Crossref OpenAlex OpenCitations
-
Allan Scott , Alan Davidson , Karen Palmer (2001). Antidepressant drugs in the treatment of anxiety disorders . Advances in Psychiatric Treatment, 7(4), 275-282. Cambridge University Press (CUP).Crossref OpenAlex OpenCitations
-
Caroline A. Macera , Elaine D. Eaker , Robert J. Jannarone , Dorothy R. Davis , Carleen H. Stoskopf (1993). A Measure of Perceived Burden among Caregivers . Evaluation & the Health Professions, 16(2), 204-211. SAGE Publications.Crossref OpenAlex OpenCitations
-
Oliver D Howes , Maria Rogdaki , James L Findon , Robert H Wichers , Tony Charman , Bryan H King et al. (2018). Autism spectrum disorder: Consensus guidelines on assessment, treatment and research from the British Association for Psychopharmacology . Journal of Psychopharmacology, 32(1), 3-29. SAGE Publications.Crossref OpenAlex OpenCitations
-
Kathryn M. Connor , Jonathan R. T. Davidson , L. Erik Churchill , Andrew Sherwood , Richard H. Weisler , Edna Foa (2000). Psychometric properties of the Social Phobia Inventory (SPIN) . British Journal of Psychiatry, 176(4), 379-386. Royal College of Psychiatrists.Crossref OpenAlex OpenCitations
-
Ailsa Russell , Daisy M Gaunt , Kate Cooper , Stephen Barton , Jeremy Horwood , David Kessler et al. (2020). The feasibility of low-intensity psychological therapy for depression co-occurring with autism in adults: The Autism Depression Trial (ADEPT) – a pilot randomised controlled trial . Autism, 24(6), 1360-1372. SAGE Publications.Crossref OpenAlex OpenCitations
-
Stefano Gabriele , Roberto Sacco , Antonio M. Persico (2014). Blood serotonin levels in autism spectrum disorder: A systematic review and meta-analysis . European Neuropsychopharmacology, 24(6), 919-929. Elsevier BV.Crossref OpenAlex OpenCitations
-
Kurt Kroenke , Robert L. Spitzer , Janet B. W. Williams (2001). The PHQ-9 . Journal of General Internal Medicine, 16(9), 606-613. Springer Science and Business Media LLC.Crossref OpenAlex OpenCitations
-
Shin Ho Park , Eleni A. Demetriou , Karen L. Pepper , Yun Ju C. Song , Emma E. Thomas , Ian B. Hickie et al. (2019). Validation of the 36‐item and 12‐item self‐report World Health Organization Disability Assessment Schedule II (WHODAS‐II) in individuals with autism spectrum disorder . Autism Research, 12(7), 1101-1111. Wiley.Crossref OpenAlex OpenCitations
-
Graham Dunn , Mohammad Maracy , Barbara Tomenson (2005). Estimating treatment effects from randomized clinical trials with noncompliance and loss to follow-up: the role of instrumental variable methods . Statistical Methods in Medical Research, 14(4), 369-395. SAGE Publications.Crossref OpenAlex OpenCitations
-
Robert L. Spitzer (1999). Validation and Utility of a Self-report Version of PRIME-MD The PHQ Primary Care Study . JAMA, 282(18), 1737. American Medical Association (AMA).Crossref OpenAlex OpenCitations
-
Nicola Wiles , Jean Mulligan , Tim J. Peters , Philip J. Cowen , Victoria Mason , David Nutt et al. (2012). Severity of depression and response to antidepressants: GENPOD randomised controlled trial . British Journal of Psychiatry, 200(2), 130-136. Royal College of Psychiatrists.Crossref OpenAlex OpenCitations
-
Alba Realpe , Nicola Mills , Lucy Beasant , Sarah Douglas *Autistic author. Learn more… , Lorcan Kenny , Dheeraj Rai (2023). Lockdown Experiences and Views on Future Research Participation of Autistic Adults in the UK During the First 6 Months of the COVID-19 Pandemic . Autism in Adulthood, 5(3), 301-310. SAGE Publications.
-
(n.d.). Autistica and James Lind Alliance Priority Setting Partnership: Autism Top 10 priorities. https://www.jla.nihr.ac.uk/priority-setting-partnerships/autism/top-10-priorities/ . Accessed 20 Sept 2023.Type: OtherCrossref
-
Jenny L. Donovan , Leila Rooshenas , Marcus Jepson , Daisy Elliott , Julia Wade , Kerry Avery et al. (2016). Optimising recruitment and informed consent in randomised controlled trials: the development and implementation of the Quintet Recruitment Intervention (QRI) . Trials, 17(1), 283. Springer Science and Business Media LLC.Crossref OpenAlex OpenCitations
-
(n.d.). STRATA Study Sites. https://strata.blogs.bristol.ac.uk/strata-sites/ . Accessed 20 Sept 2023.Type: OtherCrossref
-
(n.d.). STRATA: Information about sertraline. https://strata.blogs.bristol.ac.uk/information-about-sertraline/ . Accessed 20 Sept 2023.Type: OtherCrossref
-
Lucy Beasant , Alba Realpe , Sarah Douglas *Autistic author. Learn more… , Lorcan Kenny , Dheeraj Rai , Nicola Mills (2024). Autistic adults’ views on the design and processes within randomised controlled trials: The APRiCoT study . Autism, 28(6), 1540-1550. SAGE Publications.
-
Jack F. G. Underwood , Marcos DelPozo-Banos , Aura Frizzati , Dheeraj Rai , Ann John , Jeremy Hall (2023). Neurological and psychiatric disorders among autistic adults: a population healthcare record study . Psychological Medicine, 53(12), 5663-5673. Cambridge University Press (CUP).OpenAlex
-
(n.d.). Sealed Envelope. https://www.sealedenvelope.com/ . Accessed 20 Sept 2023.Type: OtherCrossref
-
PJ Edwards (2009). Edwards PJ, Roberts I, Clarke MJ, Diguiseppi C, Wentz R, Kwan I, Cooper R, Felix LM, Pratap S. Methods to increase response to postal and electronic questionnaires. Cochrane Database Syst Rev. 2009;2009(3):MR000008. Cochrane Database Syst Rev., 2009(3), MR000008.Type: OtherCrossref
-
(n.d.). National Institute for Health and Care Excellence (NICE). Position statement on the EQ-5D-5L value set for England. https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/technology-appraisal-guidance/eq-5d-5l . Accessed 20 Sept 2023.Type: OtherCrossref
-
(n.d.). Curtis L, Burns A: Unit Costs of Health and Social Care 2017. In. Canterbury: Personal Social Services Research Unit, University of Kent.; 2017.Type: OtherCrossref
-
(n.d.). NHS Reference Costs. https://improvement.nhs.uk/resources/reference-costs/ . Accessed 20 Sept 2023.Type: OtherCrossref
-
(n.d.). British Medical Association., Joint Formulary Committee., Pharmaceutical Society of Great Britain.: British national formulary. In. London: British Medical Association.Type: OtherCrossref